These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23293925)

  • 1. Coping with unbalanced class data sets in oral absorption models.
    Newby D; Freitas AA; Ghafourian T
    J Chem Inf Model; 2013 Feb; 53(2):461-74. PubMed ID: 23293925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of training set data distributions for modelling of passive intestinal absorption.
    Ghafourian T; Freitas AA; Newby D
    Int J Pharm; 2012 Oct; 436(1-2):711-20. PubMed ID: 22868233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-processing feature selection for improved C&RT models for oral absorption.
    Newby D; Freitas AA; Ghafourian T
    J Chem Inf Model; 2013 Oct; 53(10):2730-42. PubMed ID: 24050619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine.
    Hou T; Wang J; Li Y
    J Chem Inf Model; 2007; 47(6):2408-15. PubMed ID: 17929911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of classification regression tree in predicting oral absorption in humans.
    Bai JP; Utis A; Crippen G; He HD; Fischer V; Tullman R; Yin HQ; Hsu CP; Jiang L; Hwang KK
    J Chem Inf Comput Sci; 2004; 44(6):2061-9. PubMed ID: 15554676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(1):208-18. PubMed ID: 17238266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of highly unbalanced CYP450 data of drugs using cost sensitive machine learning techniques.
    Eitrich T; Kless A; Druska C; Meyer W; Grotendorst J
    J Chem Inf Model; 2007; 47(1):92-103. PubMed ID: 17238253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
    Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
    Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decision tree--based method for the differential diagnosis of Aortic Stenosis from Mitral Regurgitation using heart sounds.
    Pavlopoulos SA; Stasis AC; Loukis EN
    Biomed Eng Online; 2004 Jun; 3(1):21. PubMed ID: 15225347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating drug permeability with dissolution profile to develop IVIVC.
    Takano R; Kataoka M; Yamashita S
    Biopharm Drug Dispos; 2012 Oct; 33(7):354-65. PubMed ID: 22581486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harvesting classification trees for drug discovery.
    Yuan Y; Chipman HA; Welch WJ
    J Chem Inf Model; 2012 Dec; 52(12):3169-80. PubMed ID: 23110407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interesting relationship between drug absorption and melting point.
    Chu KA; Yalkowsky SH
    Int J Pharm; 2009 May; 373(1-2):24-40. PubMed ID: 19429285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing new fitness functions in genetic programming for classification with unbalanced data.
    Bhowan U; Johnston M; Zhang M
    IEEE Trans Syst Man Cybern B Cybern; 2012 Apr; 42(2):406-21. PubMed ID: 21954215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of ADME properties with substructure pattern recognition.
    Shen J; Cheng F; Xu Y; Li W; Tang Y
    J Chem Inf Model; 2010 Jun; 50(6):1034-41. PubMed ID: 20578727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial QSAR modeling of human intestinal absorption.
    Suenderhauf C; Hammann F; Maunz A; Helma C; Huwyler J
    Mol Pharm; 2011 Feb; 8(1):213-24. PubMed ID: 21142073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound optimization through data set-dependent chemical transformations.
    de la Vega de León A; Bajorath J
    J Chem Inf Model; 2013 Jun; 53(6):1263-71. PubMed ID: 23654345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
    Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.